Literature DB >> 28835785

Inhibitors of CD73 May Provide a Treatment for Cancer and Autoimmune Diseases.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2017        PMID： 28835785      PMCID： PMC5554893          DOI： 10.1021/acsmedchemlett.7b00255

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  3 in total

Review 1.  Targeting CD73 and downstream adenosine receptor signaling in triple-negative breast cancer.

Authors:  Bertrand Allard; Martin Turcotte; John Stagg
Journal:  Expert Opin Ther Targets       Date:  2014-05-06       Impact factor: 6.902

Review 2.  CD73: a potent suppressor of antitumor immune responses.

Authors:  Paul A Beavis; John Stagg; Phillip K Darcy; Mark J Smyth
Journal:  Trends Immunol       Date:  2012-04-07       Impact factor: 16.687

3.  Co-targeting of Adenosine Signaling Pathways for Immunotherapy: Potentiation by Fc Receptor Engagement.

Authors:  Rony Dahan; Jeffrey V Ravetch
Journal:  Cancer Cell       Date:  2016-09-12       Impact factor: 31.743
  3 in total
  1 in total

Review 1.  The Role of Osteoprotegerin and Its Ligands in Vascular Function.

Authors:  Luc Rochette; Alexandre Meloux; Eve Rigal; Marianne Zeller; Yves Cottin; Catherine Vergely
Journal:  Int J Mol Sci       Date:  2019-02-06       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.